HAZEL CASTRO: Open Payments
NPI 1851833107 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 28 payments from 8 companies in 2025. Trend: 2023 $348 · 2024 $640 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $165 |
| Boston Scientific Corporation | 1 | $147 |
| Phathom Pharmaceuticals, Inc. | 11 | $107 |
| Ardelyx, Inc. | 1 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Novo Nordisk Inc | 1 | $17 |
| Janssen Biotech, Inc. | 1 | $16 |
Products named: DUPIXENT, TheraSphere Y90 Glass Microspheres 10 GBq, VOQUEZNA, IBSRELA, ZENPEP, RELISTOR, Wegovy, TREMFYA.
Industry payments across NV — which companies pay providers there.
